课题基金 / 基金详情

An innovative, interdisciplinary platform for the dissection of Pneumocystis, a deadly fungal pathogen of humans

An innovative, interdisciplinary platform for the dissection of Pneumocystis, a deadly fungal pathogen of humans
一个创新的跨学科平台,用于解剖肺孢子虫(一种人类致命的真菌病原体)
批准号:
MR/V006169/1
负责人:
Olga Nev
金额:
$42.05万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我的研究项目的目标是在人类主要真菌病原体的研究中取得重大突破。肺孢子虫每年导致数十万人死亡,但只有少数几个小组正在研究这种病原体,因为目前不可能在体外培养它。我的目标是通过首次开发肺孢子虫的体外培养方法来释放这个主要的实验瓶颈。我将使用计算机代谢建模和实验表型的强大组合来解决这个问题。我的项目的潜在好处是巨大的。除了提供肺孢子虫病原体与其哺乳动物宿主的共同进化的主要见解外,我的项目还将使研究界能够在长期内导致肺孢子虫生物学和治疗的巨大进步。
英文摘要
The goal of my research project is to enable a vital breakthrough in the study of a major fungal pathogen of humans. Pneumocystis kills hundreds of thousands of people each year, and yet only a few groups are studying this pathogen because, currently, it is not possible to culture it in vitro independently of its host. My goal is to release this major experimental bottleneck by developing, for the first time, in vitro culture methods for Pneumocystis. I will address this using a powerful combination of in silico metabolic modelling and experimental phenotyping. The potential benefits of my project are vast. In addition to providing major insights into the co-evolution of Pneumocystis pathogens with their mammalian hosts, my project will empower the research community, leading, in the longer-term, to dramatic advances in Pneumocystis biology and therapy.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/mbio.02711-22
发表时间: 2023-02-28
期刊: mBio
影响因子: 6.4
作者: []
通讯作者:
Anticipatory Stress Responses and Immune Evasion in Fungal Pathogens.
真菌病原体的预期应激反应和免疫逃避。
DOI: 10.1016/j.tim.2020.09.010
发表时间: 2021
期刊: Trends in microbiology
影响因子: 15.9
作者: [Pradhan A]
通讯作者: Pradhan A
海外基金